Citadel Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Citadel Advisors’s Portfolio BSTZ Stock Details BSTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$731K	Buy	24,332 +14,605	+150%	+$403K	﹤0.01%	8966
2026 Q1	$215K	Sell	9,727 -8,873	-48%	-$199K	﹤0.01%	11267
2025 Q4	$421K	Buy	18,600 +6,893	+59%	+$154K	﹤0.01%	9439
2025 Q3	$259K	Buy	+11,707	New	+$252K	﹤0.01%	10679
2024 Q1	–	Sell	-12,124	Closed	-$203K	–	14596
2023 Q4	$203K	Buy	+12,124	New	+$196K	﹤0.01%	9931
2023 Q1	–	Sell	-16,022	Closed	-$251K	–	14742
2022 Q4	$251K	Buy	+16,022	New	+$272K	﹤0.01%	9691

Other funds holding BSTZ

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Citadel Advisors's BSTZ Position: Q2 2026 in Review

Citadel Advisors increased its BlackRock Science and Technology Term Trust (BSTZ) stake by 150% in Q2 2026, buying an estimated $403K and bringing the position to 24,332 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #8966.

Citadel Advisors first reported a position in BSTZ in Q4 2022 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold BSTZ as of Q2 2026.

Citadel Advisors held 24,332 shares of BlackRock Science and Technology Term Trust worth $731K as of Q2 2026.
Citadel Advisors bought 14,605 BlackRock Science and Technology Term Trust shares in Q2 2026, an estimated $403K.
BlackRock Science and Technology Term Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8966 holding.
Citadel Advisors first reported a position in BlackRock Science and Technology Term Trust in Q4 2022 and has held it in 6 quarters since.
151 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.